Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

General disorders and administration site conditions – page 8

  • 140 clinical trials
  • 57 recruiting
  • 120 conditions
  • 23 countries

Conditions in this area

120 conditions with trials, the busiest first

Procedural pain29Pain21Critical illness18Medical device site joint infection8Inflammation7Still's disease6Chronic fatigue syndrome5Friedreich's ataxia5Cachexia4Device related infection4Hereditary ataxia4Hot flush4Postoperative analgesia4Anxiety2Colorectal cancer2Delirium tremens2Diabetic neuropathy2Febrile neutropenia2Hip arthroplasty2Juvenile idiopathic arthritis2Menopausal symptoms2Neuropathy peripheral2Parkinson's disease2Pyrexia2+96

Clinical trials in General disorders and administration site conditions

140 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

140 clinical trials

Procedural pain

Not yet recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Bupivacaine
  • Sponsor:St Antonius Hospital

Critical illness

Not yet recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cefepime
  • Sponsor:Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

Hot flush

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Fezolinetant
  • Sponsor:Astellas Pharma Global Development Inc.

Hereditary ataxia

Not recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Sponsor:Institut De Recherches Internationales Servier IRIS

Pain+1

Not recruiting
Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · Healthy volunteers
  • Substances:Celecoxib
  • Sponsor:Codadose Inc.

Testosterone deficiency syndrome+2

Not recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Elinzanetant
  • Sponsor:Bayer AG

Inflammation

Not recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
  • Sponsor:Janssen Cilag International

Testosterone deficiency syndrome+2

Not recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Elinzanetant
  • Sponsor:Bayer AG

Anxiety+1

Not recruiting
Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Oxazepam
  • Sponsor:Neuraxpharm Pharmaceuticals S.L.

Hereditary ataxia

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fampridine
  • Sponsor:Assistance Publique Hopitaux De Paris

Substances studied in this area

The therapies tested most often in General disorders and administration site conditions trials.

Sodium Chloride18 clinical trialsParacetamol10 clinical trialsIbuprofen5 clinical trialsLidocaine Hydrochloride5 clinical trialsPlacebo5 clinical trialsRifampicin5 clinical trialsLidocaine Hydrochloride Monohydrate4 clinical trialsLinezolid4 clinical trialsPiperacillin4 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.